Both in vitro experiments in human-colon cancer cell line HT-29 and in vivo experiments in CRISPR-based xenograft mice provided the evidence that RSPO3 fusion gene was involved in the initiation and development of CRC via activating WNT signaling [14, 19]. This evidence concerns the gene RSPO3 and colonic neoplasm.